Table 2—

All-cause and cardiovascular mortality rates in the Casale Monferrato cohort of type 2 diabetes by metabolic syndrome at baseline examination (1991–1992)

All-cause mortality
Cardiovascular mortality
n deaths (rate/1,000 person-years)HR*HRHRn deaths (rate/1,000 person-years)HR*HRHR
Metabolic syndrome
    No165 (64.7)1.001.001.0085 (33.4)1.001.001.00
    Yes520 (63.0)1.05 (0.88–1.25)1.04 (0.86–1.26)1.06 (0.86–1.30)256 (31.0)1.01 (0.78–1.28)1.04 (0.78–1.39)0.95 (0.71–1.28)
Number of components
    030 (58.7)1.001.001.0011 (21.5)1.001.001.00
    1135 (66.2)1.19 (0.76–1.86)1.41 (0.86–2.31)1.37 (0.83–2.25)74 (36.3)2.39 (1.09–5.22)2.92 (1.16–7.33)2.80 (1.11–7.11)
    2249 (68.3)1.17 (0.76–1.81)1.48 (0.90–2.33)1.36 (0.85–2.21)116 (31.8)1.83 (0.85–3.97)2.44 (0.99–6.06)2.21 (0.89–5.49)
    >2271 (58.8)1.07 (0.70–1.65)1.36 (0.85–2.19)1.25 (0.78–2.02)140 (30.4)2.10 (0.98–4.52)2.80 (1.14–6.92)2.46 (0.99–6.07)
P value for trend0.620.350.930.120.690.40
  • Data are hazard ratios (HRs) (95% CI) unless otherwise indicated.

  • *

    * Adjusted for age and sex;

  • adjusted for age, sex, smoking, total cholesterol, and CHD;

  • adjusted for age, sex, smoking, total cholesterol, CHD, and HbA1c cumulative average.